Glycemic Variability in Patients With Early Type 2 Diabetes: The Impact of Improvement in β-Cell Function

Kramer, Caroline K.; Haysook Choi; Zinman, Bernard; Retnakaran, Ravi
April 2014
Diabetes Care;Apr2014, Vol. 37 Issue 4, p1116
Academic Journal
Increased glycemic variability has been reported to be associated with the risk of hypoglycemia and possibly diabetes complications and is believed to be due to β -cell dysfunction. However, it is not known whether improvement in β-cell function can reduce glycemic variability. Because short-term intensive insulin therapy (IIT) can improve β-cell function in early type 2 diabetes (T2DM), our objectivewas to determine whether the β-cell functional recovery induced by this therapy is associated with decreased glycemic variability. RESEARCH DESIGN AND METHODS Sixty-one patients with T2DM of 3.0 years mean duration underwent 4 weeks of IIT, which consisted of basal insulin detemir and premeal insulin aspart. Glucose variability was assessed in both the first and the last week by the coefficient of variation of capillary glucose on daily 6-point self-monitoring profiles. β-cell function before and after IIT was assessed with the Insulin Secretion-Sensitivity Index-2 (ISSI-2). RESULTS Between the first and the last week on IIT, 55.7% of patients had a reduction in glucose variability. Change in glucose variability was negatively correlated with the change in β-cell function (ISSI-2) (r = -0.34, P = 0.008). On multiple linear regression analyses, percentage change in ISSI-2 emerged as the only factor independently associated with the change in glucose variability (standardized b = -0.42, P = 0.03).Moreover, patients with an increase in ISSI-2 ≥ 25%experienced a reduction in glucose variability compared with their peers who had almost no change (-0.041 ± 0.06 vs. -0.0002 ± 0.04, respectively; P = 0.006). CONCLUSIONS In early T2DM, glycemic variability is a modifiable parameter that can be reduced by improving β-cell function with short-term IIT.


Related Articles

  • The effect of glycemic control on CEA, CA 19-9, amylase and lipase levels. Ata, Naim; Dal, Kürşat; Kucukazman, Metin; Yeniova, Abdullah Ö.; Karakaya, Serdar; Unsal, Oktay; Dagdeviren, Murat; Akın, Kadir O.; Baser, Salih; Beyan, Esin; Ertugrul, Derun T. // Open Medicine;2015, Vol. 10 Issue 1, p-1 

    Background: Diabetes mellitus is closely related to pancreas cancer. In this study we aimed to investigate the effect of hyperglycemia on tumor and inflammation markers, as well as pancreatic exocrine functions. Methods: A total of 98 consecutive diabetic patients with poor glycemic control, and...

  • Respuesta Glucémica e Insulínica de Pacientes con Diabetes Tipo 2 al consumo de Sopa de Calabaza Criolla (Cucúrbita Pepo L.) Enriquecida con Almidón de Banano. Torres-Zapata, Angel E.; Aparicio-Trápala, María A.; Blé-Castillo, Jorge L.; Corzo-Sosa, Carlos A. // Información Tecnológica;2012, Vol. 23 Issue 2, p71 

    The aim of this study was to determine the glycemic index value and the insulinic response of a soup containing native banana starch. The beneficial effects of resistant starch in dietary supplementation on glycemic control have been reported previously, but these parameters have not been...

  • Potential Short-Term Economic Benefits of Improved Glycemic Control. Menzin, Joseph; Langley-Hawthorne, Clare; Friedman, Mark; Boulanger, Luke; Cavanaugh, Robert // Diabetes Care;Jan2001, Vol. 24 Issue 1, p51 

    Focuses on a study which examined the potential impact of improved glycemic control on complications of diabetes and associated costs in a managed care setting. Research design and methods; Results; Conclusions.

  • Complex Interplay Among Various Glycemic Indices and Risk of Complications. Chou, Wendy // Diabetes;Jan2014, Vol. 63 Issue 1, p2 

    An introduction to the article "Complex Interplay Among Various Glycemic Indices and Risk of Complications" published within the issue is presented.

  • Diabetes. Fernandes, Tanya // Nursing Standard;8/15/2012, Vol. 26 Issue 50, p58 

    A quiz on diabetes and its complications is presented.

  • Current concepts in blood glucose monitoring. Khadilkar, Kranti Shreesh; Bandgar, Tushar; Shivane, Vyankatesh; Lila, Anurag; Shah, Nalini // Indian Journal of Endocrinology & Metabolism;2013 Supplement 3, Vol. 17 Issue S3, pS643 

    Blood glucose monitoring has evolved over the last century. The concept of adequate glycemic control and minimum glycemic variability requires an ideal, accurate and reliable glucose monitoring system. The search for an ideal blood glucose monitoring system still continues. This review explains...

  • Comparison and Correlation of Glucose Levels in Serum and Saliva of Both Diabetic and Non-diabetic Patients. Patel, Bhumika J.; Dave, Bela; Dave, Dilip; Karmakar, Payel; Shah, Mona; Sarvaiya, Bhumi // Journal of International Oral Health;Aug2015, Vol. 7 Issue 8, p70 

    Background: To detect and compare salivary glucose with plasma glucose level and postprandial blood sugar (PPBS) and fasting blood sugar (FBS) in diabetic and non-diabetic subjects. Materials and Methods: A total of 100 patients were participated in this study. They were divided into two groups,...

  • Nigella sativa Tea Improved Serum Paraoxonase-1 Activity, Glycemic Control and Lipid Profile in Type 2 Diabetes Mellitus. Mahmoud Ahmed, Mohamed; Abbas El-Shamy, Karima; Kamal El-Nabarawy, Salwa; Abdel-hamid Elbaiomy, Manal; Mahmoud El-Qattan, Ghada // Journal of Applied Sciences Research;Dec2012, Vol. 8 Issue 12, p5897 

    Background: Most studies have found that paraoxonase-1 (PON-1) activity is reduced in type1 and type 2 diabetic patients. The activity of PON-1 was found to be inversely correlated with the development of atherosclerosis. Nigella sativa (N. sativa) has favorable effect as regard glycemic control...

  • Timed Bromocriptine-QR Therapy Reduces Progression of Cardiovascular Disease and Dysglycemia in Subjects with Well-Controlled Type 2 Diabetes Mellitus. Chamarthi, Bindu; Gaziano, J. Michael; Blonde, Lawrence; Vinik, Aaron; Scranton, Richard E.; Ezrokhi, Michael; Rutty, Dean; Cincotta, Anthony H. // Journal of Diabetes Research;4/28/2015, Vol. 2015, p1 

    Background. Type 2 diabetes (T2DM) patients, including those in good glycemic control, have an increased risk of cardiovascular disease (CVD). Maintaining good glycemic control may reduce long-term CVD risk. However, other risk factors such as elevated vascular sympathetic tone and/or...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics